Synopsis
Synopsis
0
USDMF
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Carbamic Acid, (5-(4-fluorobenzoyl)-1h-benzimidazol-2-yl)-, Methyl Ester
2. Fluoromebendazole
3. Methyl(5-(4-fluorobenzoyl)-1h-benzimidazol- 2-yl)carbamate
4. R 17,889
5. R 17889
6. R-17,889
7. R-17889
1. 31430-15-6
2. Flubendazol
3. Flumoxane
4. Fluvermal
5. Flubenol
6. Methyl (5-(4-fluorobenzoyl)-1h-benzo[d]imidazol-2-yl)carbamate
7. Flubendazolum
8. Flumoxanal
9. R 17,889
10. Methyl 5-(p-fluorobenzoyl)-2-benzimidazolecarbamate
11. Methyl [5-(4-fluorobenzoyl)-1h-benzimidazol-2-yl]carbamate
12. Nsc 313680
13. R 17899
14. Nsc-313680
15. (5-(4-fluorobenzoyl)-1h-benzimidazole-2-yl)carbamic Acid Methyl Ester
16. Carbamic Acid, (5-(4-fluorobenzoyl)-1h-benzimidazol-2-yl)-, Methyl Ester
17. Methyl N-(5-(p-fluorobenzoyl)-2-benzimidazolyl)carbamate
18. Chebi:77095
19. R8m46911lr
20. R-17889
21. R-17,889
22. Nsc313680
23. Cpd000466360
24. Methyl N-[5-(4-fluorobenzoyl)-1h-benzimidazol-2-yl]carbamate
25. Methyl N-{5-[(4-fluorophenyl)carbonyl]-1h-1,3-benzodiazol-2-yl}carbamate
26. Flubendazol [inn-spanish]
27. Flubendazolum [inn-latin]
28. Smr000466360
29. Ccris 4480
30. Sr-01000759412
31. Einecs 250-624-4
32. Flicum
33. Unii-r8m46911lr
34. Flubendazole [usan:inn:ban]
35. Methyl {6-[(4-fluorophenyl)carbonyl]-1h-benzimidazol-2-yl}carbamate
36. Mfcd00871999
37. Methyl N-[6-(4-fluorobenzoyl)-1h-benzimidazol-2-yl]carbamate
38. Flubendazole (flutelmium)
39. Flubendazole [mi]
40. 2-benzimidazolecarbamic Acid, 5-(p-fluorobenzoyl)-, Methyl Ester
41. Flubendazole (usan/inn)
42. Flubendazole [inn]
43. Flubendazole [usan]
44. Flubendazole [mart.]
45. Mls000759477
46. Mls001424042
47. Mls006010905
48. Flubendazole [who-dd]
49. Schembl167185
50. Chembl1454946
51. Dtxsid8023058
52. Flubendazole For System Suitability
53. Hms2051a18
54. Hms2090i16
55. Hms3393a18
56. Hms3714d06
57. Flubendazole [ep Monograph]
58. Act02027
59. Bcp34258
60. Hy-b0294
61. Zinc3830847
62. S1837
63. Akos015894917
64. Akos015960439
65. Ac-8716
66. Ccg-100887
67. Ccg-267614
68. Db08974
69. Nc00137
70. Ncgc00246966-01
71. Ncgc00246966-03
72. Ncgc00246966-12
73. As-12271
74. F0825
75. Ft-0626436
76. D04200
77. D70276
78. Ab00639981-06
79. Ab00639981-08
80. Ab00639981_09
81. Flubendazol, Vetranal(tm), Analytical Standard
82. 430f156
83. A820846
84. Q241992
85. Flubendazole, Antibiotic For Culture Media Use Only
86. Q-201119
87. Sr-01000759412-4
88. Sr-01000759412-5
89. Methyl [5-(4-fluorobenzoyl)benzimidazol-2-yl]carbamate
90. Flubendazol, European Pharmacopoeia (ep) Reference Standard
91. Methyl 5-(4-fluorobenzoyl)-1h-benzo[d]imidazol-2-ylcarbamate
92. [5-(4-fluorobenzoyl)benzimidazol-2-yl]carbamic Acid Methyl Ester
93. Methyl (5-(4-fluorobenzoyl)-1h-benzo-[d]imidazol-2-yl)carbamate
94. Methyl (6-(4-fluorobenzoyl)-1h-benzo[d]imidazol-2-yl)carbamate
95. Carbamicacid, [5-(4-fluorobenzoyl)-1h-benzimidazol-2-yl]-methylester
96. N-{5-[(4-fluorophenyl)carbonyl]benzimidazol-2-yl}methyloxymethanamide
97. Carbamic Acid, N-[5-(4-fluorobenzoyl)-1h-benzimidazol-2-yl]-, Methyl Ester
98. Flubendazole For System Suitability, European Pharmacopoeia (ep) Reference Standard
99. N-[6-[(4-fluorophenyl)-oxomethyl]-1h-benzimidazol-2-yl]carbamic Acid Methyl Ester
100. Nsc 313680; Nsc313680; Nsc-313680; R 17899; R17899; R-17899
Molecular Weight | 313.28 g/mol |
---|---|
Molecular Formula | C16H12FN3O3 |
XLogP3 | 2.9 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 4 |
Exact Mass | 313.08626942 g/mol |
Monoisotopic Mass | 313.08626942 g/mol |
Topological Polar Surface Area | 84.1 Ų |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 454 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Antinematodal Agents
Substances used in the treatment or control of nematode infestations. They are used also in veterinary practice. (See all compounds classified as Antinematodal Agents.)
P - Antiparasitic products, insecticides and repellents
P02 - Anthelmintics
P02C - Antinematodal agents
P02CA - Benzimidazole derivatives
P02CA05 - Flubendazole
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
80
PharmaCompass offers a list of Flubendazole API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Flubendazole manufacturer or Flubendazole supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Flubendazole manufacturer or Flubendazole supplier.
PharmaCompass also assists you with knowing the Flubendazole API Price utilized in the formulation of products. Flubendazole API Price is not always fixed or binding as the Flubendazole Price is obtained through a variety of data sources. The Flubendazole Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Fluvermal manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fluvermal, including repackagers and relabelers. The FDA regulates Fluvermal manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fluvermal API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Fluvermal manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Fluvermal supplier is an individual or a company that provides Fluvermal active pharmaceutical ingredient (API) or Fluvermal finished formulations upon request. The Fluvermal suppliers may include Fluvermal API manufacturers, exporters, distributors and traders.
click here to find a list of Fluvermal suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Fluvermal CEP of the European Pharmacopoeia monograph is often referred to as a Fluvermal Certificate of Suitability (COS). The purpose of a Fluvermal CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Fluvermal EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Fluvermal to their clients by showing that a Fluvermal CEP has been issued for it. The manufacturer submits a Fluvermal CEP (COS) as part of the market authorization procedure, and it takes on the role of a Fluvermal CEP holder for the record. Additionally, the data presented in the Fluvermal CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Fluvermal DMF.
A Fluvermal CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Fluvermal CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Fluvermal suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Fluvermal as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Fluvermal API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Fluvermal as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Fluvermal and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Fluvermal NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Fluvermal suppliers with NDC on PharmaCompass.
Fluvermal Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Fluvermal GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Fluvermal GMP manufacturer or Fluvermal GMP API supplier for your needs.
A Fluvermal CoA (Certificate of Analysis) is a formal document that attests to Fluvermal's compliance with Fluvermal specifications and serves as a tool for batch-level quality control.
Fluvermal CoA mostly includes findings from lab analyses of a specific batch. For each Fluvermal CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Fluvermal may be tested according to a variety of international standards, such as European Pharmacopoeia (Fluvermal EP), Fluvermal JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Fluvermal USP).